🇮🇳 Biocon Ltd

Company Update 14-10-2026 08:25:59 IST

Overview: Secured earliest licensed launch dates for Pebrilzo® (bPertuzumab) following a global patent settlement and license agreement with Genentech.

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest